To assess the impact of immunosuppressive therapy and the disease state on CPT1A induction, CPT1A expression was examined in patients with newly diagnosed RA who were not treated with disease-modifying anti-rheumatic drugs or underwent corticosteroid treatment within 3 months before recruitment to the study. This evidence concerns the gene CPT1A and rheumatoid arthritis.